Skip to Main Content

Paper Details

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations.
Transfusion
187
2003
Author NameAffiliation
Brian R JacksonDartmouth-Hitchcock Medical Center
  • 1 - 1

Datasets

Release 1.2